Cyclodextrin-PEI-Tat Polymer as a Vector for Plasmid DNA Delivery to Placenta Mesenchymal Stem Cells

BioNanoScience

Volumn 1, Issue 3, 2011, Pages 89-96

  Lai, Wing Fu ^b   Tang, Gu Ping ^b,d   Wang, Xin ^a   Li, Guo ^a   Yao, Hong ^a,b   Shen, Zan ^b,c   Lu, Gang ^a   Poon, Wai Sang ^a   Kung, Hsiang Fu ^a   Lin, Marie C M ^a,b  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

^c SHANGHAI JIAO TONG UNIVERSITY   (China)

^d ZHEJIANG UNIVERSITY   (China)

Author keywords

Nucleic acid delivery; Placenta mesenchymal stem cells; Poly(ethylenimine); Tat peptide; cyclodextrin

Indexed keywords

BIOMOLECULES; CELL CULTURE; CYCLODEXTRINS; DRUG THERAPY; EFFICIENCY; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; NUCLEIC ACIDS; PEPTIDES; STEM CELLS; SULFUR COMPOUNDS;

CHARACTERISTIC PEAKS; DISULFIDE EXCHANGE; MESENCHYMAL STEM CELL; NUCLEIC ACID DELIVERIES; POLY(ETHYLENIMINE); POST TREATMENT; TAT PEPTIDE; TRANSFECTION EFFICIENCY;

DNA;

EID: 84862575345     PISSN: 21911630     EISSN: 21911649     Source Type: Journal    
DOI: 10.1007/s12668-011-0010-9     Document Type: Article

References (46)

1. De Sousa, P. A., Galea, G., Turner, M. (2006). The road to providing human embryo stem cells for therapeutic use: the UK experience. Reproduction, 132, 681-689.
2. Sell, S. (2006). Potential gene therapy strategies for cancer stem cells. Current Gene Therapy, 6, 579-591.
3. Lai, W. F. (2011). Delivery of therapeutics: current status and its relevance to regenerative innovations. Recent Patents on Nanomedicine, 1, 7-18.
4. Davila, J. C., Cezar, G. G., Thiede, M., Strom, S., Miki, T., Trosko, J. (2004). Use and application of stem cells in toxicology. Toxicological Sciences, 79, 214-223.
5. Gesslbauer, B., Krenn, E., Zenzmaier, C., Preisegger, K. H., Kungl, A. J. (2006). Lessons from the stem cell proteome. Current Stem Cell Research & Therapy, 1, 395-409.
6. Hashino, S., Kobayashi, S., Takahata, M., Onozawa, M., Nakagawa, M., Kawamura, T., et al. (2008). Graft-versus-tumor effect after reduced-intensity allogeneic hematopoietic stem cell transplantation in a patient with advanced colon cancer. International Journal of Clinical Oncology, 13, 176-180.
7. Nagai, T., Shiojima, I., Matsuura, K., Komuro, I. (2005). Promotion of cardiac regeneration by cardiac stem cells. Circulation Research, 97, 615-617.
8. Morris, K. V., & Rossi, J. J. (2006). Lentivirus-mediated RNA interference therapy for human immunodeficiency virus type 1 infection. Human Gene Therapy, 17, 479-486.
9. Check, E. (2003). Cancer risk prompts US to curb gene therapy. Nature, 422, 7.
10. Ferreira, E., Potier, E., Logeart-Avramoglou, D., Salomskaite-Davalgiene, S., Mir, L. M., Petite, H. (2008). Optimization of a gene electrotransfer method for mesenchymal stem cell transfection. Gene Therapy, 15, 537-544.
11. Kolodka, T. M., Garlick, J. A., Taichman, L. B. (1998). Evidence for keratinocyte stem cells in vitro: long term engraftment and persistence of transgene expression from retrovirus-transduced keratinocytes. Proc Natl Acad Sci USA, 95, 4356-4361.
12. Vassalli, G., Bueler, H., Dudler, J., von Segesser, L. K., Kappenberger, L. (2003). Adeno-associated virus (AAV) vectors achieve prolonged transgene expression in mouse myocardium and arteries in vivo: a comparative study with adenovirus vectors. International Journal of Cardiology, 90, 229-238.
13. Marwick, C. (2003). FDA halts gene therapy trials after leukaemia case in France. BMJ, 326, 181.
14. Park, T. G., Jeong, J. H., Kim, S. W. (2006). Current status of polymeric gene delivery systems. Advanced Drug Delivery Reviews, 58, 467-486.
15. Mintzer, M. A., & Simanek, E. E. (2009). Nonviral vectors for gene delivery. Chemistry Review, 109, 259-302.
16. Lai, W. F., & Lin, M. C. (2009). Nucleic acid delivery with chitosan and its derivatives. Journal of Controlled Release, 134, 158-168.
17. Lai, W. F., & Lin, M. C. (2010). Chemical derivatization of chitosan for plasmid DNA delivery: present and future. In S. K. Kim (Ed.), Chitin, chitosan and their derivatives: biological activities and industrial applications (pp. 69-82). Florida: CRC.
18. Lai, W. F. (2011). In vivo nucleic acid delivery with PEI and its derivatives: current status and perspectives. Expert Review of Medical Devices, 8, 173-185.
19. Ortiz Mellet, C., Garcia Fernandez, J. M., Benito, J. M. (2011). Cyclodextrin-based gene delivery systems. Chemical Society Reviews, 40, 1586-1608.
20. Gonzalez, H., Hwang, S. J., & Davis, M. E. (1999). New class of polymers for the delivery of macromolecular therapeutics. Bioconjugate Chemistry, 10, 1068-1074.
21. Davis, M. E. (2009). The first targeted delivery of siRNA in humans via a self-assembling, cyclodextrin polymer-based nanoparticle: from concept to clinic. Molecular Pharmaceutics, 6, 659-668.
22. Davis, M. E., & Brewster, M. E. (2004). Cyclodextrin-based pharmaceutics: past, present and future. Nature Reviews. Drug Discovery, 3, 1023-1035.
23. Lai, L. H., Jiang, Q. Y., Chen, D., Hu, Y. P., Yu, H., Wang, Q. Q., et al. (2009). Peptide TAT modified polyethylenimine-beta-cyclodextrin for gene delivery. Zhejiang Da Xue Xue Bao. Yi Xue Ban, 38, 15-23.
24. Li, J., & Loh, X. J. (2008). Cyclodextrin-based supramolecular architectures: syntheses, structures, and applications for drug and gene delivery. Advanced Drug Delivery Reviews, 60, 1000-1017.
25. Tang, G. P., Guo, H. Y., Alexis, F., Wang, X., Zeng, S., Lim, T. M., et al. (2006). Low molecular weight polyethylenimines linked by beta-cyclodextrin for gene transfer into the nervous system. The Journal of Gene Medicine, 8, 736-744.
26. Eguchi, A., Akuta, T., Okuyama, H., Senda, T., Yokoi, H., Inokuchi, H., et al. (2001). Protein transduction domain of HIV-1 Tat protein promotes efficient delivery of DNA into mammalian cells. Journal of Biological Chemistry, 276, 26204-26210.
27. Snyder, E. L., & Dowdy, S. F. (2004). Cell penetrating peptides in drug delivery. Pharmaceutical Research, 21, 389-393.
28. Lai, W. F., & Lin, M. C. M. (2010). Synthesis and properties of chitosan-PEI graft copolymers as vectors for nucleic acid delivery. Journal of Materials Science and Engineering, 4, 34-40.
29. In 't Anker, P. S., Scherjon, S. A., van der Keur Kleijburg, C., de Groot-Swings, G. M., Claas, F. H., Fibbe, W. E., et al. (2004). Isolation of mesenchymal stem cells of fetal or maternal origin from human placenta. Stem Cells, 22, 1338-1345.
30. Lu, L. L., Liu, Y. J., Yang, S. G., Zhao, Q. J., Wang, X., Gong, W., et al. (2006). Isolation and characterization of human umbilical cord mesenchymal stem cells with hematopoiesis-supportive function and other potentials. Haematologica, 91, 1017-1026.
31. Chen, C. P., Liu, S. H., Huang, J. P., Aplin, J. D., Wu, Y. H., Chen, P. C., et al. (2009). Engraftment potential of human placenta-derived mesenchymal stem cells after in utero transplantation in rats. Human Reproduction, 24, 154-165.
32. Pittenger, M. F., Mackay, A. M., Beck, S. C., Jaiswal, R. K., Douglas, R., Mosca, J. D., et al. (1999). Multilineage potential of adult human mesenchymal stem cells. Science, 284, 143-147.
33. Chang, C. M., Kao, C. L., Chang, Y. L., Yang, M. J., Chen, Y. C., Sung, B. L., Tsai, T. H., Chao, K. C., Chiou, S. H., Ku, H. H. (2007). Placenta-derived multipotent stem cells induced to differentiate into insulin-positive cells. Biochemical and Biophysical Research Communications, 357, 414-420.
34. Pun, S. H., Bellocq, N. C., Liu, A. J., Jensen, G., Machemer, T., Quijano, E., et al. (2004). Cyclodextrin-modified polyethylenimine polymers for gene delivery. Bioconjugate Chemistry, 15, 831-840.
35. Forrest, M. L., Gabrielson, N., Pack, D. W. (2005). Cyclodextrin-polyethylenimine conjugates for targeted in vitro gene delivery. Biotechnology and Bioengineering, 89, 416-423.
36. Arima, H., Kihara, F., Hirayama, F., Uekama, K. (2001). Enhancement of gene expression by polyamidoamine dendrimer conjugates with alpha-, beta-, and gamma-cyclodextrins. Bioconjugate Chemistry, 12, 476-484.
37. Croyle, M. A., Roessler, B. J., Hsu, C. P., Sun, R., Amidon, G. L. (1998). Beta cyclodextrins enhance adenoviral-mediated gene delivery to the intestine. Pharmaceutical Research, 15, 1348-1355.
38. Lawrencia, C., Mahendran, R., Esuvaranathan, K. (2001). Transfection of urothelial cells using methyl-beta-cyclodextrin solubilized cholesterol and Dotap. Gene Therapy, 8, 760-768.
39. Parolini, O., Alviano, F., Bagnara, G. P., Bilic, G., Buhring, H. J., Evangelista, M., et al. (2008). Concise review: isolation and characterization of cells from human term placenta: outcome of the first international Workshop on Placenta Derived Stem Cells. Stem Cells, 26, 300-311.
40. Murphy, J. M., Fink, D. J., Hunziker, E. B., Barry, F. P. (2003). Stem cell therapy in a caprine model of osteoarthritis. Arthritis and Rheumatism, 48, 3464-3474.
41. Tang, Y. L., Zhao, Q., Zhang, Y. C., Cheng, L. L., Liu, M. Y., Shi, J. H., et al. (2004). Autologous mesenchymal stem cell transplantation induce VEGF and neovascularization in ischemic myocardium. Regulatory Peptides, 117, 3-10.
42. Petite, H., Viateau, V., Bensaid, W., Meunier, A., de Pollak, C., Bourguignon, M., et al. (2000). Tissue-engineered bone regeneration. Nature Biotechnology, 18, 959-963.
43. Jorgensen, C., Djouad, F., Apparailly, F., Noel, D. (2003). Engineering mesenchymal stem cells for immunotherapy. Gene Therapy, 10, 928-931.
44. Meinel, L., Hofmann, S., Betz, O., Fajardo, R., Merkle, H. P., Langer, R., et al. (2006). Osteogenesis by human mesenchymal stem cells cultured on silk biomaterials: comparison of adenovirus mediated gene transfer and protein delivery of BMP-2. Biomaterials, 27, 4993-5002.
45. Yao, H., Ng, S. S., Tucker, W. O., Tsang, Y. K. T., Man, K., Wang, X. M., et al. (2009). The gene transfection efficiency of a folate-PEI600-cyclodextrin nanopolymer. Biomaterials, 30, 5793-5803.
46. Zhang, P., Zhang, H., Hu, S. S., Chen, L. G., Wei, Y. J. (2005). Plasmid transfection of rat bone marrow mesenchymal stem cells by cationic lipid for gene-modified cell transplantation therapy. Zhongguo Yi Xue Ke Xue Yuan Xue Bao, 27, 504-508.